Lanthanide complexes with a new luminescent iminophosphonamide ligand bearing phenylbenzothiazole substituents

A new iminophosphonamine Ph2P(HNPbt)(NPbt) (1, HL) bearing chromophore 2-(phen-2'-yl)-1,3-benzothiazole (Pbt) substituents was synthesized and introduced into lanthanide complexes. It was found that salt metathesis reactions between KL (2) generated in situ and LnCl3 lead to the formation of tris-iminophosphonamide complexes [LnL2]L (Ln = Y (3), Sm (4), Gd (5), Dy (6)), regardless of the 2/LnCl3 ratio. Compounds 3-6 consist of a cationic fragment [LnL2]+, where the lanthanide atom is surrounded by two rigidly κ4-coordinated ligands, and an L- anion residing in the outer coordination sphere. Iminophosphonamine 1 shows a rare excitation wavelength-dependent two-band luminescence in the solid state. For compounds containing the deprotonated form, namely potassium salt KL and complexes of Gd and Dy, a single-band luminescence with the color changing from turquoise to orange was observed. The Sm complex reveals a set of a few narrow well-resolved bands corresponding to the f-f transitions against the background of the outer-sphere ligand's emission.

Synthesis and photophysical properties of rare earths (La, Nd, Gd, Y, Ho) complexes with silanediamido ligands bearing chelating phenylbenzothiazole chromophore

New silanediamide ligand bearing chromophore 2-phenylbenzothiazole (Pbt) groups SiMe2(HNPbt)2 (1H) was synthesized and introduced in the lanthanide complexes. It was found that independently of the stoichiometry of the salt metathesis...

Structural Diversity and Multielectron Reduction Reactivity of Samarium(II) Iodido-β-diketiminate Complexes Dependent on Tetrahydrofuran Content

The molecular structures of complexes [Sm(Nacnac)I(thf)_n] (Nacnac = HC(C(Me)Ndipp)₂^-, dipp = 2,6-diisopropylphenyl, thf = tetrahydrofuran) depending on the number of thf ligands are studied. The complete removal of thf from a known complex [Sm(Nacnac)I(thf)₂] leads to a tetranuclear product [Sm(Nacnac)I]₄ (4). The partial removal of thf results in mixtures of dinuclear [Sm₂(Nacnac)₂I₂(thf)] (2), trinuclear [Sm₃(Nacnac)₃I₃(thf)] (3), and tetranuclear [Sm₄(Nacnac)₄I₄(thf)₂] (4*) complexes and 4, depending on the conditions. The reaction of solvent-free SmI₂ with 1 equiv of K(Nacnac) results mainly in [Sm(Nacnac)₂] (1), while the interaction of 4 with certain amounts of thf allows obtaining pure 2 and 3 (with the admixture of 4*). Complex 4* is the exact dimer of 2, and both compounds are stable in solutions. Reactions with 3 and 4 as reductants are studied. 4 is oxidized by I₂ to stoichiometrically yield two products, mixed-valent tetranuclear [Sm₄(Nacnac)₄I₅] (5) and binuclear [Sm(Nacnac)I₂]₂ (6) complexes. In the reaction of 4 with ⁿBu₃PTe, a trinuclear complex [Sm₃(Nacnac)₃(μ-I)₃(μ₃-E)₂] (8, E = I or Te) is formed in small amounts, with the formation of 6 as the second product. 3 serves as a two-electron reductant in the reaction with ⁿBu₃PTe to yield a trinuclear complex [Sm₃(Nacnac)₃I₃(μ-Te₂)] (7). Complexes 2, 4, 4*, 5, 6, and 8 possess a unique flat Sm_xI_y core of heavy atoms, which is assumed to be a consequence of the Nacnac ligand geometry.

Synthesis and photophysical properties of rare earth complexes bearing silanediamido ligands Me2Si(NAryl)22− (Aryl = Dipp, Mes)

Luminescence of the newly obtained silanediamides of rare earths was investigated. The triplet states of the ligands {Me2Si(NAryl)2}2− (Aryl = Dpp, Mes) were determined by the emission of Gd complexes, and the bright emission of Tb3+ was observed.

On the usability of salt metathesis reactions for the synthesis of sterically crowded tris-formamidinate Ln(iii) complexes: success and limits. Spontaneous reduction of Eu(iii) to Eu(ii)

New homoleptic complexes of Eu3+ and Nd3+ bearing three bulky N,N′-bis(diisopropylphenyl)formamidinates were prepared using salt metathesis in a toluene medium. In the presence of THF, the sterically-induced reduction of Eu3+ to Eu2+ was observed.

3D Printed Gene-activated Octacalcium Phosphate Implants for Large Bone Defects Engineering

The aim of the study was the development of three-dimensional (3D) printed gene-activated implants based on octacalcium phosphate (OCP) and plasmid DNA encoding VEGFA. The first objective of the present work involved design and fabrication of gene-activated bone substitutes based on the OCP and plasmid DNA with VEGFA gene using 3D printing approach of ceramic constructs, providing the control of its architectonics compliance to the initial digital models. X-ray diffraction, scanning electron microscopy (SEM), Fourier transform infrared spectroscopy, and compressive strength analyses were applied to investigate the chemical composition, microstructure, and mechanical properties of the experimental samples. The biodegradation rate and the efficacy of plasmid DNA delivery in vivo were assessed during standard tests with subcutaneous implantation to rodents in the next stage. The final part of the study involved substitution of segmental tibia and mandibular defects in adult pigs with 3D printed gene-activated implants. Biodegradation, osteointegration, and effectiveness of a reparative osteogenesis were evaluated with computerized tomography, SEM, and a histological examination. The combination of gene therapy and 3D printed implants manifested the significant clinical potential for effective bone regeneration in large/critical size defect cases.

Synthesis and luminescence studies of lanthanide complexes (Gd, Tb, Dy) with phenyl- and 2-pyridylthiolates supported by a bulky β-diketiminate ligand. Impact of the ligand environment on terbium(iii) emission

Structure-dependent photoluminescence was studied for lanthanide complexes with widespread Nacnac ligands, supplemented by thiolates; notable antenna properties of the latter are revealed.

[Features of silent myocardial ischemia in male patients with coronary disease]

The results of a study dealing with the specific features of silent myocardial ischemia (SMI) in male patients aged over 70 years are presented. Prolonged episodes of silent myocardial ischemia have been ascertained to be more frequently encountered in patients with ischemic heart disease (IHD) as high functional class angina pectoris on exertion, postinfarct cardiosclerosis, arterial hypertension, atherogenic blood lipid disturbances and they increase a total risk for SMI provided that they are combined. All this leads to destabilization of coronary blood flow and becomes a trigger for the development of prognostically significant cardiac arrhythmias by complicating the course of IHD and increasing the cost of drugs.